Literature DB >> 33561938

Translational Relevance of Mouse Models of Atopic Dermatitis.

Justin Choi1,2, Nishadh Sutaria1, Youkyung Sophie Roh1, Zachary Bordeaux1, Martin P Alphonse1, Shawn G Kwatra1, Madan M Kwatra2.   

Abstract

The complexity of atopic dermatitis (AD) continues to present a challenge in the appropriate selection of a mouse model because no single murine model completely recapitulates all aspects of human AD. This has been further complicated by recent evidence of the distinct AD endotypes that are dictated by unique patterns of inflammation involving Th1, Th2, Th17, and Th22 axes. A review of currently used mouse models demonstrates that while all AD mouse models consistently exhibit Th2 inflammation, only some demonstrate concomitant Th17 and/or Th22 induction. As the current understanding of the pathogenic contributions of these unique endotypes and their potential therapeutic roles expands, ongoing efforts to maximize a given mouse model's homology with human AD necessitates a close evaluation of its distinct immunological signature.

Entities:  

Keywords:  atopic dermatitis; dermatology; eczema; immunology; mouse models

Year:  2021        PMID: 33561938      PMCID: PMC7914954          DOI: 10.3390/jcm10040613

Source DB:  PubMed          Journal:  J Clin Med        ISSN: 2077-0383            Impact factor:   4.241


  54 in total

1.  Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges.

Authors:  Mao-Qiang Man; Yutaka Hatano; Seung H Lee; Mona Man; Sandra Chang; Kenneth R Feingold; Donald Y M Leung; Walter Holleran; Yoshikazu Uchida; Peter M Elias
Journal:  J Invest Dermatol       Date:  2007-08-02       Impact factor: 8.551

2.  Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase Inhibitors: Selectivity, Cellular Activity, and Effect on Cytokines Associated with Skin Inflammation and Skin Architecture Changes.

Authors:  Chen Dong; Charlotte Virtucio; Olga Zemska; Grober Baltazar; Yasheen Zhou; Diogo Baia; Shannon Jones-Iatauro; Holly Sexton; Shamra Martin; Joshua Dee; Yvonne Mak; Maliwan Meewan; Fernando Rock; Tsutomu Akama; Kurt Jarnagin
Journal:  J Pharmacol Exp Ther       Date:  2016-06-27       Impact factor: 4.030

3.  Design, synthesis and biological evaluation of novel benzoxaborole derivatives as potent PDE4 inhibitors for topical treatment of atopic dermatitis.

Authors:  Zhaoxing Chu; Qinlong Xu; Qihua Zhu; Xiaodong Ma; Jiajia Mo; Gaofeng Lin; Yan Zhao; Yuanfeng Gu; Lincui Bian; Li Shao; Jing Guo; Wenfeng Ye; Jiaming Li; Guangwei He; Yungen Xu
Journal:  Eur J Med Chem       Date:  2021-01-12       Impact factor: 6.514

4.  A novel JAK inhibitor JTE-052 reduces skin inflammation and ameliorates chronic dermatitis in rodent models: Comparison with conventional therapeutic agents.

Authors:  Atsuo Tanimoto; Yuichi Shinozaki; Yasuo Yamamoto; Yoshiaki Katsuda; Eriko Taniai-Riya; Kaoru Toyoda; Kochi Kakimoto; Yukari Kimoto; Wataru Amano; Noriko Konishi; Mikio Hayashi
Journal:  Exp Dermatol       Date:  2017-07-03       Impact factor: 3.960

5.  Establishment of a Mouse Model of Atopic Dermatitis by Deleting Ikk2 in Dermal Fibroblasts.

Authors:  Satoshi Nunomura; Naoko Ejiri; Midori Kitajima; Yasuhiro Nanri; Kazuhiko Arima; Yasutaka Mitamura; Tomohito Yoshihara; Kazuki Fujii; Keizo Takao; Johji Imura; Hans Joerg Fehling; Kenji Izuhara; Isao Kitajima
Journal:  J Invest Dermatol       Date:  2019-01-19       Impact factor: 8.551

6.  Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation.

Authors:  Yihua Cai; Xiaoyan Shen; Chuanlin Ding; Chunjian Qi; Kejia Li; Xia Li; Venkatakrishna R Jala; Huang-ge Zhang; Tian Wang; Jie Zheng; Jun Yan
Journal:  Immunity       Date:  2011-10-06       Impact factor: 31.745

7.  Development of atopic dermatitis-like skin lesion with IgE hyperproduction in NC/Nga mice.

Authors:  H Matsuda; N Watanabe; G P Geba; J Sperl; M Tsudzuki; J Hiroi; M Matsumoto; H Ushio; S Saito; P W Askenase; C Ra
Journal:  Int Immunol       Date:  1997-03       Impact factor: 4.823

8.  Skin-specific expression of IL-33 activates group 2 innate lymphoid cells and elicits atopic dermatitis-like inflammation in mice.

Authors:  Yasutomo Imai; Koubun Yasuda; Yoshiko Sakaguchi; Takashi Haneda; Hitoshi Mizutani; Tomohiro Yoshimoto; Kenji Nakanishi; Kiyofumi Yamanishi
Journal:  Proc Natl Acad Sci U S A       Date:  2013-08-05       Impact factor: 11.205

9.  Interleukin 31, a cytokine produced by activated T cells, induces dermatitis in mice.

Authors:  Stacey R Dillon; Cindy Sprecher; Angela Hammond; Janine Bilsborough; Maryland Rosenfeld-Franklin; Scott R Presnell; Harald S Haugen; Mark Maurer; Brandon Harder; Janet Johnston; Susan Bort; Sherri Mudri; Joseph L Kuijper; Tom Bukowski; Pamela Shea; Dennis L Dong; Maria Dasovich; Francis J Grant; Luann Lockwood; Steven D Levin; Cosette LeCiel; Kim Waggie; Heather Day; Stavros Topouzis; Janet Kramer; Rolf Kuestner; Zhi Chen; Don Foster; Julia Parrish-Novak; Jane A Gross
Journal:  Nat Immunol       Date:  2004-06-06       Impact factor: 25.606

10.  Effects of chloromethylisothiazolinone/methylisothiazolinone (CMIT/MIT) on Th2/Th17-related immune modulation in an atopic dermatitis mouse model.

Authors:  Han-Na Go; Seung-Hwa Lee; Hyun-Ju Cho; Jae-Rin Ahn; Mi-Jin Kang; So-Yeon Lee; Soo-Jong Hong
Journal:  Sci Rep       Date:  2020-03-05       Impact factor: 4.379

View more
  2 in total

1.  Lymph-derived chemokines direct early neutrophil infiltration in the lymph nodes upon Staphylococcus aureus skin infection.

Authors:  Jingna Xue; Yujia Lin; Darellynn Oo; Jianbo Zhang; Ava Zardynezhad; Flavia Neto de Jesus; Matthew Stephens; Luiz G N de Almeida; Daniel Young; Antoine Dufour; Shan Liao
Journal:  Proc Natl Acad Sci U S A       Date:  2022-08-01       Impact factor: 12.779

2.  Dendritic cell immunoreceptor drives atopic dermatitis by modulating oxidized CaMKII-involved mast cell activation.

Authors:  Xiaoyan Luo; Jingsi Chen; Huan Yang; Xinyue Hu; Martin P Alphonse; Yingchun Shen; Yuko Kawakami; Xiaoying Zhou; Wei Tu; Toshiaki Kawakami; Mei Wan; Nathan K Archer; Hua Wang; Peisong Gao
Journal:  JCI Insight       Date:  2022-03-08
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.